AUTOLOGOUS ANTI-GD2 CAR-T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA

被引：0
|
作者：
Chiavelli, C. [1 ]
Rovesti, G. [1 ,2 ,3 ]
Prapa, M. [1 ,4 ]
Neri, G. [1 ,2 ]
Pugliese, G. [1 ,5 ]
Trudu, L. [1 ,2 ,3 ]
Silingardi, M. [1 ]
Dall'Ora, M. [6 ]
Golinelli, G. [1 ,7 ]
Grisendi, G. [1 ]
Bestagno, M. [8 ]
Spano, C. [6 ]
Papapietro, R. V. [3 ]
Depenni, R. [3 ]
Di Emidio, K. [3 ]
Pasetto, A. [9 ,10 ]
Silva, D. Nascimento [10 ]
Feletti, A. [11 ]
Berlucchi, S. [12 ]
Iaccarino, C. [12 ]
Pavesi, G. [12 ]
Dominici, M. [1 ,3 ,6 ]
机构：
[1] Dept Med & Surg Sci Children & Adults, Div Oncol, Lab Cellular Therapy, Modena, Italy
[2] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy
[3] Univ Hosp Modena & Reggio Emilia, Univ Hosp Modena, Dept Hematol & Oncol, Modena, Italy
[4] Univ Barleti, Dept Med Tech Sci, Tirana, Albania
[5] Guys Hosp, Leucid Bio Ltd, London, England
[6] Evotec Modena Srl, Evotec, Modena, Italy
[7] Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA
[8] Icgeb, Trieste, Italy
[9] Oslo Univ Hosp, Sect Cell Therapy, Radiumhosp, Oslo, Norway
[10] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[11] Univ Verona, Dept Neurosci Biomed & Movement Sci, Neurosurg Unit, Verona, Italy
[12] Univ Hosp Modena, Div Neurosurg, Dept Neurosci, Modena, Italy
来源：
HUMAN GENE THERAPY | 2023年 / 34卷 / 21-22期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P099
引用
收藏
页码：A42 / A43
页数：2
相关论文
共 50 条
  • [21] Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma
    Golinelli, Giulia
    Grisendi, Giulia
    Dall'Ora, Massimiliano
    Casari, Giulia
    Spano, Carlotta
    Talami, Rebecca
    Banchelli, Federico
    Prapa, Malvina
    Chiavelli, Chiara
    Rossignoli, Filippo
    Candini, Olivia
    D'Amico, Roberto
    Nasi, Milena
    Cossarizza, Andrea
    Casarini, Livio
    Dominici, Massimo
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [22] Combining locoregional CAR-T cells, autologous plus allogeneic tumor lysate vaccination and levamisole in treatment of glioblastoma
    Altinoz, Meric A.
    Ozpinar, Alp
    Hacker, Emily
    Ozpinar, Aysel
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (06) : 797 - 808
  • [23] CD171-and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
    Andersch, Lena
    Radke, Josefine
    Klaus, Anika
    Schwiebert, Silke
    Winkler, Annika
    Schumann, Elisa
    Grunewald, Laura
    Zirngibl, Felix
    Flemmig, Carina
    Jensen, Michael C.
    Rossig, Claudia
    Joussen, Antonia
    Henssen, Anton
    Eggert, Angelika
    Schulte, Johannes H.
    Kuenkele, Annette
    BMC CANCER, 2019, 19 (01)
  • [24] CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
    Lena Andersch
    Josefine Radke
    Anika Klaus
    Silke Schwiebert
    Annika Winkler
    Elisa Schumann
    Laura Grunewald
    Felix Zirngibl
    Carina Flemmig
    Michael C. Jensen
    Claudia Rossig
    Antonia Joussen
    Anton Henssen
    Angelika Eggert
    Johannes H. Schulte
    Annette Künkele
    BMC Cancer, 19
  • [25] Generation of allogeneic CAR-T circumvents functional deficits in patientderived autologous product for glioblastoma
    Shaikh, Muhammad Vaseem
    Salim, Sabra K.
    Wei, Jeffrey
    Maich, William T.
    Anand, Alisha A.
    Tang, Oliver Young
    Subapanditha, Minomi K.
    Suk, Yujin
    Singh, Manoj
    Alizada, Zahra
    Brakel, Benjamin
    Dimitrov, Vassil
    Tabunshchyk, Zoya
    Brown, Kevin
    Vora, Parvez
    Binder, Zev
    Venugopal, Chitra
    Moffat, Jason
    Singh, Sheila K.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] CAR-T cells in glioblastoma: towards multi-targeted therapy
    Huebner, J.
    Nickl, V
    AlSalkini, M.
    Grams, B.
    Loehr, M.
    Hudecek, M.
    Nerreter, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 197 - 198
  • [27] Anti-GD2 CAR NKT Cells Are Safe and Produce Antitumor Responses in Patients with Relapsed/Refractory Neuroblastoma
    Heczey, Andras
    Courtney, Amy
    Ghatwai, Nisha
    Thakkar, Sachin
    Rathi, Purva
    Xu, Xin
    Ngai, Ho
    Di Piero, Erica J.
    Grilley, Bambi
    Sher, Andrew
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    MOLECULAR THERAPY, 2022, 30 (04) : 28 - 28
  • [28] Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas
    Zuo, Pengcheng
    Li, Yaopeng
    He, Chi
    Wang, Tantan
    Zheng, Xu
    Liu, Hao
    Wu, Zhen
    Zhang, Junting
    Liao, Xuebin
    Zhang, Liwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] Implications of TET2 in CAR-T Cell Activity and Target Response to CAR-T Cell Therapy: Lessons Learned from T Cells
    Pasca, Sergiu
    Jurj, Ancuta
    Constantinescu, Catalin
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : 13 - 21
  • [30] B7-H3-TARGETED CAR-T AND CAR-NK CELLS AGAINST HUMAN GLIOBLASTOMA
    Tachi, Tetsuro
    Kijima, Noriyuki
    Kuroda, Hideki
    Murakami, Koki
    Hosen, Naoki
    Kishima, Haruhiko
    NEURO-ONCOLOGY, 2024, 26
12345